-
Mashup Score: 0The 2022 generation - Nature Cancer - 1 year(s) ago
Twelve early career investigators share experiences from the process of starting their laboratories throughout the past year, and reflect on the challenges faced and the opportunities seized.
Source: NatureCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 6NOT-Gated CD93 CAR T Cells Effectively Target AML with Minimized Endothelial Cross-Reactivity - 1 year(s) ago
CD93 CAR T cells eliminate AML in preclinical models without targeting hematopoietic progenitor cells, and a NOT-gated CAR engineering strategy mitigates on-target, off-tumor toxicity to endothelial cells.
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 4The transition phase: preparing to launch a laboratory - 2 year(s) ago
The process of starting a laboratory varies between institutions. However, there are universal tasks all investigators will need to address when launching their laboratories. In this piece, we provide a brief summary of considerations for incoming group leaders to centralize this information for the scientific community.
Source: Trends in Biochemical SciencesCategories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 7Building a laboratory and networks during the COVID-19 pandemic - 2 year(s) ago
The coronavirus disease 2019 (COVID-19) pandemic has created unprecedented obstacles for new investigators to traverse. The pandemic’s impact exacerbates inequities for groups historically excluded from science. We provide recommendations to support junior faculty, including women and faculty from groups historically excluded from science, in establishing laboratories during the pandemic and…
Source: Trends in Biochemical SciencesCategories: Allergy-Immunology, Latest HeadlinesTweet
💫Recruiting, securing funding, building a network – early career investigators face many challenges! In “The 2022 generation” hear the inspiring stories of 12 PIs who started their teams in the past year. #newPI #2022InReview https://t.co/j79Ng1oJfQ https://t.co/g9Vuaq1mQm